openPR Logo
Press release

What's driving the Intravenous Immunoglobulins Market Growth? Prominent Players: CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Bio Products Laboratory Limited, Biotest AG, Innovent Biologics, Inc.

07-05-2019 08:07 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

What's driving the Intravenous Immunoglobulins Market Growth?

The Global Intravenous Immunoglobulins Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Intravenous Immunoglobulins Market Size, Share and Global Trend By Indication (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain-Barré Syndrome (GBS), Immune Thrombocytopenic Purpura (ITP), Multifocal Motor Neuropathy (MMN)), Form (Liquid, Lyophilized), End User (Hospitals, Clinics, Homecare) & Geography Forecast till 2025

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Intravenous Immunoglobulins market. Additionally, increasing per capita income and rising living standards is expected to drive the global Intravenous Immunoglobulins market during the forecast period 2018-2025.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Intravenous Immunoglobulins market.

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

The Asia Pacific Intravenous Immunoglobulins market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

The analysis conducted in the report is based on industry leading tools and techniques. The report prepared by Fortune Business Insights, offers innovative strategies based on various analysis. The information offered is collected from reliable primary and secondary sources. The report also provides information about key companies operating in the market.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis: CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Bio Products Laboratory Limited, Biotest AG, Innovent Biologics, Inc.

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593

SEGMENTATION

By Indication

· Primary Immunodeficiency
· Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
· Guillain-Barré Syndrome (GBS)
· Immune Thrombocytopenic Purpura (ITP)
· Multifocal Motor Neuropathy (MMN)
· Others

By Form

· Liquid
· Lyophilized

By End User

· Hospitals
· Clinics
· Homecare

By Geography

· North America (the U.S., and Canada)
· Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (China, India, Japan, Australia, South East Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America
· Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)

Major Table of Content For Intravenous Immunoglobulins Market:
1. Introduction
2. Executive Summary
3. Market Dynamics
4. Key Insights
5. Global Intravenous Immunoglobulins Market Analysis, Insights and Forecast
6. North America Intravenous Immunoglobulins Market Analysis, Insights and Forecast
7. Europe Intravenous Immunoglobulins Market Analysis, Insights and Forecast
8. Asia Pacific Intravenous Immunoglobulins Market Analysis, Insights and Forecast
9. Middle East and Africa Intravenous Immunoglobulins Market Analysis, Insights and Forecast, 2014-2025
10. Latin America Intravenous Immunoglobulins Market Analysis, Insights and Forecast, 2014-2025
11. Competitive Landscape
12. Company Profile
13. Conclusion

Request Customization of this Report@ https://www.fortunebusinessinsights.com/enquiry/customization/intravenous-immunoglobulins-market-100593

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Intravenous Immunoglobulins Market Growth? Prominent Players: CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Bio Products Laboratory Limited, Biotest AG, Innovent Biologics, Inc. here

News-ID: 1797296 • Views:

More Releases from Fortune Business Insights Pvt. Ltd.

Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 2030
Luxury Goods Market Size Report, Trends, Overview, Outlook & Future Growth By 20 …
The global luxury goods market size was valued at USD 272.74 billion in 2022. The market is anticipated to grow from USD 284.00 billion in 2023 to USD 392.40 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. Luxury products signify the status symbol of an individual. Businesses focus on high-income populations with visually appealing designs and technology-integrated products. For instance, NFC-installed chips in jewelry; a product called
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2027 | Key Companies Profiled: BSG Glass, NSG Groupe, Schott AG
With 17.2% CAGR, Smart Glass market Market to Hit USD 15,788.0 Million by 2022-2 …
The global smart glass market size is anticipated to reach USD 15,788.0 million by 2027, owing to the rise in the use of smart glass for different applications such as aerospace, marine, architectural, and automotive. Smart glass or switchable glass is glazing or a glass with altered transmission properties as and when heat, light, or voltage is applied. They are capable of changing their appearance from opaque to translucent to transparent
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast 2020-2027
Non-alcoholic Beverages Market Segmentation& Analysis, Industry Growth Forecast …
According to Fortune Business Insights ™, the global non-alcoholic beverages market size is anticipated to rise significantly on account of the current trend of health and fitness and the rising inclination towards healthy beverages. The value of this market was USD 919.13 billion in 2019 and is expected to rise at a CAGR of 8.20% between 2020 to 2027 to reach USD 1,257.77 billion by the end of 2027. List of
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Development, Trends and Forecasts to 2027
Intravenous Iron Drugs Market 2022: Global Technology, Segmentation, Growth, Dev …
Global Intravenous Iron Drugs Market Size research report 2022 offers an in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. The demand for refractive surgeries is anticipated to increase, attributed to the rise in the aging population and excessive use of digital devices, which has increased the screen time of the world population due to the

All 5 Releases


More Releases for Intravenous

Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Peripheral Intravenous Catheter Market
New research report offers a comprehensive analysis of the “Peripheral Intravenous Catheter Market: Asia Pacific Regional Market to Witness the Fastest Growth Throughout the Forecast Period: Global Industry Analysis & Opportunity Assessment, 2016-2021“The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/2827 Peripheral intravenous catheter is a sophisticated medical device widely used to
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to